These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8912402)

  • 1. Oral administration of glycine and polyamine receptor antagonists blocks ethanol withdrawal seizures.
    Kotlinska J; Liljequist S
    Psychopharmacology (Berl); 1996 Oct; 127(3):238-44. PubMed ID: 8912402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NMDA/glycine receptor antagonist, L-701,324, produces discriminative stimuli similar to those of ethanol.
    Kotlinska J; Liljequist S
    Eur J Pharmacol; 1997 Jul; 332(1):1-8. PubMed ID: 9298919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dextromethorphan attenuates ethanol withdrawal syndrome in rats.
    Erden BF; Ozdemirci S; Yildiran G; Utkan T; Gacar N; Ulak G
    Pharmacol Biochem Behav; 1999 Mar; 62(3):537-41. PubMed ID: 10080248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lorazepam and MK-801 effects on behavioral and electrographic indices of alcohol withdrawal sensitization.
    Veatch LM; Becker HC
    Brain Res; 2005 Dec; 1065(1-2):92-106. PubMed ID: 16313888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seizures during ethanol withdrawal are blocked by focal microinjection of excitant amino acid antagonists into the inferior colliculus and pontine reticular formation.
    Riaz A; Faingold CL
    Alcohol Clin Exp Res; 1994 Dec; 18(6):1456-62. PubMed ID: 7695044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selectivity of the protective effects of dihydropyridine calcium channel antagonists against the ethanol withdrawal syndrome.
    Watson WP; Little HJ
    Brain Res; 2002 Mar; 930(1-2):111-22. PubMed ID: 11879801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of escitalopram on ethanol withdrawal syndrome in rats.
    Sağlam E; Kayir H; Celik T; Uzbay T
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1027-32. PubMed ID: 16650516
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-NAME precipitates catatonia during ethanol withdrawal in rats.
    Uzbay IT
    Behav Brain Res; 2001 Feb; 119(1):71-6. PubMed ID: 11164527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticonvulsive effects of kappa-opioid receptor modulation in an animal model of ethanol withdrawal.
    Beadles-Bohling AS; Wiren KM
    Genes Brain Behav; 2006 Aug; 5(6):483-96. PubMed ID: 16923153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Repeated ethanol withdrawal delays development of focal seizures in hippocampal kindling.
    Veatch LM; Gonzalez LP
    Alcohol Clin Exp Res; 1999 Jul; 23(7):1145-50. PubMed ID: 10443979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Administration of eliprodil during ethanol withdrawal in the neonatal rat attenuates ethanol-induced learning deficits.
    Thomas JD; Garcia GG; Dominguez HD; Riley EP
    Psychopharmacology (Berl); 2004 Sep; 175(2):189-95. PubMed ID: 15064913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dizocilpine in withdrawal seizure-prone (WSP) and withdrawal seizure-resistant (WSR) mice.
    Crabbe J; Young ER; Dorow J
    Pharmacol Biochem Behav; 1994 Mar; 47(3):443-50. PubMed ID: 8208761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex.
    Bristow LJ; Hutson PH; Kulagowski JJ; Leeson PD; Matheson S; Murray F; Rathbone D; Saywell KL; Thorn L; Watt AP; Tricklebank MD
    J Pharmacol Exp Ther; 1996 Nov; 279(2):492-501. PubMed ID: 8930150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant synaptic activation of N-methyl-D-aspartate receptors underlies ethanol withdrawal hyperexcitability.
    Hendricson AW; Maldve RE; Salinas AG; Theile JW; Zhang TA; Diaz LM; Morrisett RA
    J Pharmacol Exp Ther; 2007 Apr; 321(1):60-72. PubMed ID: 17229881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MK-801 can exacerbate or attenuate behavioral alterations associated with neonatal alcohol exposure in the rat, depending on the timing of administration.
    Thomas JD; Fleming And SL; Riley EP
    Alcohol Clin Exp Res; 2001 May; 25(5):764-73. PubMed ID: 11371726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyamemazine decreases ethanol intake in rats and convulsions during ethanol withdrawal syndrome in mice.
    Naassila M; Legrand E; d'Alche-Birée F; Daoust M
    Psychopharmacology (Berl); 1998 Dec; 140(4):421-8. PubMed ID: 9888617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased GABA effectiveness in the inferior colliculus neurons during ethanol withdrawal in rats susceptible to audiogenic seizures.
    N'Gouemo P; Caspary DM; Faingold CL
    Brain Res; 1996 Jun; 724(2):200-4. PubMed ID: 8828569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and chronic tianeptine treatments attenuate ethanol withdrawal syndrome in rats.
    Uzbay T; Kayir H; Celik T; Yüksel N
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 May; 30(3):478-85. PubMed ID: 16412550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of memantine during withdrawal mitigates overactivity and spatial learning impairments associated with neonatal alcohol exposure in rats.
    Idrus NM; McGough NN; Riley EP; Thomas JD
    Alcohol Clin Exp Res; 2014 Feb; 38(2):529-37. PubMed ID: 24428701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MK-801 potently inhibits alcohol withdrawal seizures in rats.
    Morrisett RA; Rezvani AH; Overstreet D; Janowsky DS; Wilson WA; Swartzwelder HS
    Eur J Pharmacol; 1990 Jan; 176(1):103-5. PubMed ID: 2155795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.